Frazier Healthcare Partners Buying MatrixCare From ResMed
Private equity firm Frazier Healthcare Partners is set to acquire MatrixCare, a long-term care software platform, from medical device giant ResMed.
If you've been following ResMed's ongoing effort to streamline its business, here's the latest chapter: private equity firm Frazier Healthcare Partners has agreed to acquire MatrixCare, ResMed's long-term and post-acute care software unit. It's a notable divestiture that signals ResMed wants to sharpen its focus on its core sleep and respiratory device business rather than juggling a sprawling health-IT portfolio.
MatrixCare is a software platform built specifically for long-term care settings — think skilled nursing facilities, home health agencies, and senior living communities. These operators rely on tools like MatrixCare to handle everything from clinical documentation to billing, so the platform has a sticky user base in a sector that's growing as the U.S. population ages. For Frazier Healthcare Partners, a firm that specializes in healthcare-focused investments, snapping up a niche software business with that kind of built-in demand makes a lot of strategic sense.
Read more Arthur J. Gallagher Snaps Up Canadian Broker Wilson M. Beck →
For ResMed shareholders, the move could be a net positive if the proceeds get recycled into higher-margin core operations or returned to investors. ResMed has been under some pressure to prove it can execute efficiently after making several software acquisitions over the years — MatrixCare was one of its bigger bets in health IT. Letting that go suggests management is listening to calls for focus and capital discipline.
The financial terms of the deal were not disclosed in the announcement, so it's hard to gauge exactly what ResMed is getting for the asset or how it stacks up against what they originally paid. Investors and analysts will likely be watching for any commentary on deal economics when ResMed next reports earnings. Either way, this transaction is a reminder that in today's market, doing less — but better — can be a winning corporate strategy.
Continue reading at SeekingAlpha.
